The role of apoptosis in 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine)-mediated radiosensitization

Clinical Cancer Research

Volumn 7, Issue 2, 2001, Pages 314-319

  Lawrence, T S ^a   Davis, M A ^a   Hough, A ^a   Rehemtulla, A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; GEMCITABINE; NUCLEOSIDE ANALOG; RADIOSENSITIZING AGENT;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL SPECIFICITY; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; DRUG SPECIFICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; RADIOSENSITIZATION; SOLID TUMOR;

APOPTOSIS; CASPASE 3; CASPASES; CELL SURVIVAL; COBALT RADIOISOTOPES; COLONIC NEOPLASMS; COUMARINS; DEOXYCYTIDINE; DNA DAMAGE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENZYME ACTIVATION; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; OLIGOPEPTIDES; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0035127288     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The role of single-agent Gemcitabine in the treatment of non-small-cell lung cancer
2. Gemcitabine: Single-agent and combination therapy in non-small cell lung cancer
3. Radiosensitization by Gemcitabine
4. Experimental drugs and drug combinations in pancreatic cancer
5. Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis
6. bcl-2 protein inhibits chemotherapy-induced apoptosis in neuroblastoma
7. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
8. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
9. A license to kill
10. Protease activation during apoptosis: Death by a thousand cuts
11. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer
12. Mean inactivation dose: A useful concept for intercomparison of human cell survival curves
13. The effect of activation of wild type p53 function on fluoropyrimidine-mediated radiosensitization
14. Transfected c-myc and c-Ha-ras modulate radiation-induced apoptosis in rat embryo cells
15. Radiation-induced apoptosis: Relevance to radiotherapy
16. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
17. High molecular weight DNA fragmentation: A critical event in nucleoside analogue-induced apoptosis in leukemia cells
18. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α, and ceramide
19. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
20. Apoptotic pathways: The roads to ruin
21. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells
22. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine)
23. The role of p53 in Gemcitabine-mediated cytotoxicity and radiosensitization
24. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study
25. A phase I study of Gemcitabine in combination with radiation therapy in patients with localized unresectable pancreatic cancer